Amnion Animal Science Corp. Information

Amnion Animal Sciences Corp. develops, manufactures and markets a family of products based upon the patent pending TriAmino and TriAmino Fulvate™ molecules, which includes proprietary product formulations that have been specifically bioengineered to promote rapid healing in companion animals, large animals and livestock. The lead Amniogen™ treatments derived from these miracle molecules have demonstrated, in a variety of research and investigational studies, the ability to rapidly treat a broad spectrum of topical wounds, including all degrees of burns, topical lesions and ulcers, fungi and spores, in a manner that provides instant relief from pain, itching, bleeding, burning and inflammation. The technology has also demonstrated clear evidence of safe, effective treatment of acute clinical bovine mastitis in clinical investigational studies performed within the Animal and Dairy Science Department at the University of Georgia. Amnion Animal Sciences’ headquarters are located in Santa Monica, California, with principle management based in Seattle, Washington. International operations are managed from remote facilites in Europe and Latin America.